Page 53 - JCTR-11-3

Journal of Clinical and
Translational Research Greek propolis use in COVID-19: Trial protocol

doi: 10.22088/cjim.11.2.191 doi: 10.1186/s12916-020-01726-3
64. Falcão SI, Vale N, Gomes P, et al. Phenolic profiling of portuguese 73. Wei CJ, Hu XX, Ye GM, Yang JM, Cheng ZS, Wang XH. Time
propolis by LC-MS spectrometry: Uncommon propolis rich in and risk factors of viral clearance in COVID-19 patients.
flavonoid glycosides. Phytochem Anal. 2013;24(4):309-318. Chin Med J (Engl). 2021;134(17):2131-2133.
doi: 10.1002/pca.2412 doi: 10.1097/CM9.0000000000001467
65. García-Viguera C, Ferreres F, Tomás-Barberán FA. Study of 74. Disease Control and Health Statistics. COVID-19 Cases,
Canadian propolis by GC-MS and HPLC. Z Naturforsch C. Hospitalizations, and Deaths by Vaccination Status.
1993;48(9-10):731-735. Washington State Department of Health; 2022. Available
doi: 10.1515/znc-1993-9-1009 from: https://doh.wa.gov/sites/default/files/2022-02/421-010-
casesinnotfullyvaccinated.pdf [Last accessed on 2022 Aug 18].
66. World Health Organization (WHO). Guidelines for Good
Clinical Practice (GCP) for Trials on Pharmaceutical 75. Kissler SM, Fauver JR, Mack C, et al. Viral dynamics of
Products. WHO Technical Report Series No. 850. 1995. SARS-CoV-2 variants in vaccinated and unvaccinated
Available from: https://apps.who.int/medicinedocs/pdf/ persons. N Engl J Med. 2021;385(26):2489-2491.
whozip13e/whozip13e.pdf [Last accessed 2022 Aug 28]. doi: 10.1056/NEJMc2102507
67. International Conference on Harmonisation of Technical 76. Centers for Disease Control and Prevention (CDC).
Requirements for Registration of Pharmaceuticals for Human COVID-19 Hospitalizations; 2022. Available from: https://gis.
Use. ICH Harmonized Tripartite Guideline. Guideline for cdc.gov/grasp/covidnet/COVID19_5.html [Last accessed on
Good Clinical Practice E6(R1); 1996. Available from: https:// 2022 Dec 03].
www.ich.org/fileadmin/public_web_site/ich_products/
guidelines/efficacy/e6/e6_r1_guideline.pdf [Last accessed 77. Centers for Disease Control and Prevention (CDC).
on 2022 Aug 08]. COVID-19 Vaccinations in the United States.
November 30, 30AD. Available from: https://covid.cdc.gov/
68. Newton PN, Schellenberg D, Ashley EA, et al. Quality
assurance of drugs used in clinical trials: Proposal for covid-data-tracker/#vaccinations_vacc-people-additional-
adapting guidelines. BMJ. 2015;350:h602. dose-totalpop [Last accessed on 2022 Dec 03].
78. Berretta AA, Nascimento AP, Bueno PCP, De Oliveira
doi: 10.1136/bmj.h602
Lima Leite Vaz MM, Marchetti JM. Propolis standardized
69. Schoenfeld D. The asymptotic properties of nonparametric extract (EPP-AF ), an innovative chemically and biologically
®
tests for comparing survival distributions. Biometrika. reproducible pharmaceutical compound for treating
1981;68(1):316-319. wounds. Int J Biol Sci. 2012;8(4):512-521.
doi: 10.1093/biomet/68.1.316 doi: 10.7150/ijbs.3641
70. Zhong B. How to calculate sample size in randomized 79. EPP-AF Apis Flora. EPP-AF - the Standardized Propolis
®
®
controlled trial? J Thorac Dis. 2009;1(1):51-54. Extract that is an Assurance of Quality, Effectiveness and
71. Armstrong RA. When to use the Bonferroni correction. Safety. Available from: https://cienciadapropolis.com.br/en/
Ophthalmic Physiol Optics. 2014;34(5):502-508. what-is-epp-af/epp-af [Last accessed on 2022 Jul 20].
doi: 10.1111/opo.12131 80. Hossain KS, Hossain MG, Moni A, et al. Prospects of honey
in fighting against COVID-19: Pharmacological insights
72. Rees EM, Nightingale ES, Jafari Y, et al. COVID-19 length of
hospital stay: A systematic review and data synthesis. BMC and therapeutic promises. Heliyon. 2020;6(12):e05798.
Med. 2020;18(1):270. doi: 10.1016/j.heliyon.2020.e05798

Volume 11 Issue 3 (2025) 47 doi: 10.36922/jctr.24.00073